Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | cMet RNA CAR T cells |
Synonyms | |
Therapy Description |
cMet RNA CAR T cells are autologous T-cells transfected with RNA that codes for a chimeric antigen receptor comprised of a portion of anti-Met and CD3-zeta chain linked to CD-137, which targets T-cells to c-MET expressing tumor cells, resulting in selective toxicity (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
cMet RNA CAR T cells | cMet CAR-mRNA electroporated autologous T lymphocytes | MET Immune Cell Therapy 1 MET Inhibitor 59 | cMet RNA CAR T cells are autologous T-cells transfected with RNA that codes for a chimeric antigen receptor comprised of a portion of anti-Met and CD3-zeta chain linked to CD-137, which targets T-cells to c-MET expressing tumor cells, resulting in selective toxicity (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|